24/7 Customer Support

China Medical Plastic Packaging Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2027

China Medical Plastic Packaging Market- (By Plastic Type- PET, PP, LDPE, HDPE and Others; By Packaging Type- Primary, Secondary and Tertiary; By Drug Type- Oral Drugs, Injectables, Topical, Ocular/ Ophthalmic, Nasal, Sublingual, Pulmonary, Transdermal, IV Drugs, Devices and Others; By End User- Pharma Manufacturing, Contract Packaging, Retail Pharmacy and Institutional Pharmacy; and By Country) - Industry Dynamics, Market Size and Opportunity Forecast, 2027

  • Published On: 27-May-2022  |  Format: pdfpowerpointexcel  |  Report ID: AA0522251
    Delivery: 2 to 4 Hours

FREQUENTLY ASKED QUESTIONS

Improved safety, infection resistance, and lower cost for hospitals and patients, among others are some of the advantages of the medical plastic packaging.

PVC is the most widely used plastic material in medical applications followed by PE, PP, PS and PET.

Improved safety, infection resistance, and lower cost for hospitals and patients, among others are some of the advantages of the medical plastic packaging.

The China medical plastic packaging market held a market value of US$ 4,317.8 Million in 2021 and is projected to reach US$ 6,777.8 Million by the year 2027.

The expected growth rate of the China medical plastic packaging market is 7.8%.

On the basis of drug type, the medical plastic packaging market is segmented into oral drugs, injectables, topical, ocular/ ophthalmic, nasal, sublingual, pulmonary, transdermal, IV drugs, devices and others.

New investments in plastic recycling capabilities in healthcare provides a lucrative growth opportunity in the China medical plastic packaging market.

The COVID-19 outbreak has directly affected the medical plastic packaging industry in a positive way, as the demand for cost-effective, high-quality and efficient healthcare packaging solutions have increased.

The major factor responsible for the growth of the market includes surging incidence of lifestyle related chronic diseases and awareness among individuals toward the benefits of packaged healthcare and rising demand for plastic packaging in the healthcare & pharmaceutical industry.

Stringent regulatory norms on plastics usage are a restraining factor which inhibits the growth of the market during the forecast period.

The tertiary segment is anticipated to grow at the highest CAGR during the forecast period. 

Plastic type, packaging type, drug type and end user are the segments to invest in over the assessment period in the China medical plastic packaging market.

The key players operating in the market include Amcor Plc, FLEX Ltd., EVCO Plastics, Gerresheimer AG, Hebei Xinfuda Plastic Products Co. Ltd., Linuo Group, Shandong Pharmaceutical Glass Co. Ltd., Tongyu Pharmaceutical Packaging Co., Ltd., Hangzhou Plastics Industry Co., Ltd. and Hebei First Rubber Medical Technology Co., Ltd. among others.